Welcome to Helix Talk, an educational podcast for healthcare students and providers covering real-life clinical pearls, professional pharmacy topics, and drug therapy discussions.

This podcast is provided by pharmacists and faculty members at Rosal Franklin University College of Pharmacy.

This podcast contains general information for educational purposes only. This is not professional

advice and should not be used in lieu of obtaining advice from a qualified health care provider.

And now on to the show. Welcome to Helix Talk episode 89. I'm your co-host Dr. Kane. And I'm

Dr. Schumann. And unfortunately, we do not have Dr. Patel with us today,

but we'd like to wish her congratulations on her new baby

and her current maternity leave.

So we're going to miss her today, and hopefully she'll come back soon.

Yeah, but hopefully we won't get into too much trouble in her absence.

So today's topic is teaching old drugs new tricks, dramatic drug price increases with the FDA unapproved drugs initiative.

And really what we're talking about today is an initiative brought about in 2006 by the FDA

why it came out and how it's actually impacted both drug price increases but also drug shortages

as well. Yeah, so it's a chance to really go back, I think talk about some about our clinical practice

right now, but really also going back and looking at an evaluation about where pharmacy's gone

over the last few decades.

And so, again, be careful about leaving the two of us alone.

I think we kind of have a Bill and Ted moment here as far as kind of getting,

looking at some time machines moving back in the past and zipping back to the forward too.

So Dr. Schumann, with your permission, I think that we should have our inaugural sound effect of the

Helix Talk podcast, which would be a time machine sound. Let's do it. Now this is a Pandora's

box. So if we open this box, we may

...